Malignant Melanoma

Also known as: Malignant Melanomas / Melanoma, Malignant / Malignant melanoma (morphologic abnormality) / Melanoma / Malignant melanoma (disorder) / Melanoma malignant

Drug	Drug Name	Drug Description
DB05258	Interferon alfa	An immunomodulator used to treat hepatitis B and C as well as certain types of cancer including cutaneous T-cell lymphoma and renal cell carcinoma.
DB00105	Interferon alfa-2b	A form of recombinant human interferon used to treat hepatitis B and C infection, genital warts, hairy cell leukemia, follicular lymphoma, malignant melanoma, and AIDs-related Kaposi's sarcoma.
DB00309	Vindesine	A vinca alkaloid derived from vinblastine used for various types of malignancies, but mainly acute lymphocytic leukemia (ALL).

Drug	Drug Name	Target	Type
DB05258	Interferon alfa	Interferon alpha/beta receptor 1	target
DB05258	Interferon alfa	Cytochrome P450 1A2	enzyme
DB00105	Interferon alfa-2b	Interferon alpha/beta receptor 2	target
DB00105	Interferon alfa-2b	Interferon alpha/beta receptor 1	target
DB00105	Interferon alfa-2b	Cytochrome P450 1A2	enzyme
DB00105	Interferon alfa-2b	Interferon alpha-2	target
DB00309	Vindesine	Tubulin beta-1 chain	target
DB00309	Vindesine	Cytochrome P450 3A4	enzyme

Drug	Drug Name	Phase	Status	Count
DB00041	Aldesleukin	Not Available	Completed	1
DB16680	Cadonilimab	Not Available	Not Yet Recruiting	1
DB08912	Dabrafenib	Not Available	Completed	1
DB00099	Filgrastim	Not Available	Active Not Recruiting	1
DB11679	Fruquintinib	Not Available	Not Yet Recruiting	1
DB06186	Ipilimumab	Not Available	No Longer Available	1
DB04440	Nebularine	Not Available	Completed	1
DB09035	Nivolumab	Not Available	No Longer Available	1
DB09037	Pembrolizumab	Not Available	Completed	1
DB00853	Temozolomide	Not Available	Not Yet Recruiting	1
DB08911	Trametinib	Not Available	Completed	1
DB11714	Durvalumab	0	Withdrawn	1
DB01095	Fluvastatin	0	Withdrawn	1
DB06186	Ipilimumab	0	Withdrawn	1
DB09035	Nivolumab	0	Withdrawn	1
DB11771	Tremelimumab	0	Withdrawn	1
DB00041	Aldesleukin	1	Completed	1
DB11595	Atezolizumab	1	Completed	2
DB11967	Binimetinib	1	Terminated	1
DB19291	Cancer/testis antigen 1	1	Completed	1
DB00958	Carboplatin	1	Completed	1
DB05239	Cobimetinib	1	Completed	3
DB00531	Cyclophosphamide	1	Completed	2
DB00531	Cyclophosphamide	1	Recruiting	1
DB00531	Cyclophosphamide	1	Terminated	1
DB08912	Dabrafenib	1	Terminated	1
DB11687	E-6201	1	Terminated	1
DB12213	Etaracizumab	1	Completed	1
DB01073	Fludarabine	1	Completed	1
DB01073	Fludarabine	1	Recruiting	1
DB01073	Fludarabine	1	Terminated	1
DB17296	Gebasaxturev	1	Completed	1
DB00724	Imiquimod	1	Completed	1
DB06186	Ipilimumab	1	Completed	3
DB06186	Ipilimumab	1	Terminated	1
DB00480	Lenalidomide	1	Completed	1
DB18942	Lorigerlimab	1	Recruiting	1
DB00683	Midazolam	1	Terminated	1
DB18249	Nadunolimab	1	Completed	1
DB06132	Nivolumab	1	Completed	1
DB09035	Nivolumab	1	Completed	4
DB09035	Nivolumab	1	Unknown Status	1
DB06603	Panobinostat	1	Completed	1
DB09037	Pembrolizumab	1	Active Not Recruiting	1
DB09037	Pembrolizumab	1	Completed	4
DB09037	Pembrolizumab	1	Recruiting	1
DB09037	Pembrolizumab	1	Terminated	1
DB00642	Pemetrexed	1	Completed	1
DB00073	Rituximab	1	Completed	1
DB11689	Selumetinib	1	Completed	1
DB15283	Tebentafusp	1	Completed	1
DB11815	Tilarginine	1	Active Not Recruiting	1
DB17082	Tinlorafenib	1	Terminated	1
DB15147	Tinostamustine	1	Unknown Status	1
DB11771	Tremelimumab	1	Enrolling by Invitation	1
DB15113	Utomilumab	1	Completed	1
DB05238	Vemurafenib	1	Completed	1
DB08881	Vemurafenib	1	Completed	7
DB08881	Vemurafenib	1	Terminated	1
DB17500	Vidutolimod	1	Completed	1
DB00541	Vincristine	1	Completed	1
DB18871	Vobramitamab duocarmazine	1	Recruiting	1
DB13101	4SC-202	1 / 2	Completed	1
DB05103	AN-9	1 / 2	Terminated	1
DB15018	Agatolimod	1 / 2	Terminated	2
DB00041	Aldesleukin	1 / 2	Terminated	1
DB11595	Atezolizumab	1 / 2	Completed	1
DB11967	Binimetinib	1 / 2	Completed	1
DB15694	Cedazuridine	1 / 2	Recruiting	1
DB14707	Cemiplimab	1 / 2	Active Not Recruiting	1
DB15210	Chlorotoxin	1 / 2	Terminated	1
DB05806	Cositecan	1 / 2	Terminated	1
DB00531	Cyclophosphamide	1 / 2	Terminated	1
DB00531	Cyclophosphamide	1 / 2	Unknown Status	1
DB00851	Dacarbazine	1 / 2	Completed	1
DB01262	Decitabine	1 / 2	Completed	1
DB01262	Decitabine	1 / 2	Recruiting	1
DB01234	Dexamethasone	1 / 2	Terminated	1
DB11718	Encorafenib	1 / 2	Completed	1
DB01073	Fludarabine	1 / 2	Terminated	1
DB17293	Hiltonol	1 / 2	Withdrawn	1
DB15850	IMM-101	1 / 2	Terminated	1
DB05003	Imexon	1 / 2	Completed	1
DB06186	Ipilimumab	1 / 2	Active Not Recruiting	1
DB09035	Nivolumab	1 / 2	Recruiting	1
DB01229	Paclitaxel	1 / 2	Completed	1
DB17495	Pegenzileukin	1 / 2	Active Not Recruiting	1
DB09037	Pembrolizumab	1 / 2	Completed	2
DB09037	Pembrolizumab	1 / 2	Recruiting	1
DB09037	Pembrolizumab	1 / 2	Withdrawn	1
DB18446	RAPA-201	1 / 2	Recruiting	1
DB15185	Rasdegafusp alfa	1 / 2	Withdrawn	1
DB13017	Rovalpituzumab tesirine	1 / 2	Terminated	1
DB18439	SCIB1	1 / 2	Terminated	1
DB00020	Sargramostim	1 / 2	Active Not Recruiting	1
DB00877	Sirolimus	1 / 2	Recruiting	1
DB15283	Tebentafusp	1 / 2	Withdrawn	1
DB00853	Temozolomide	1 / 2	Completed	1
DB04937	Tertomotide	1 / 2	Completed	1
DB00313	Valproic acid	1 / 2	Terminated	1
DB00459	Acitretin	2	Terminated	1
DB00041	Aldesleukin	2	Completed	2
DB11595	Atezolizumab	2	Completed	1
DB11595	Atezolizumab	2	Terminated	1
DB06626	Axitinib	2	Completed	1
DB05983	Bardoxolone methyl	2	Withdrawn	1
DB00112	Bevacizumab	2	Completed	2
DB11967	Binimetinib	2	Active Not Recruiting	1
DB11967	Binimetinib	2	Not Yet Recruiting	1
DB11967	Binimetinib	2	Recruiting	1
DB01222	Budesonide	2	Completed	1
DB11666	Buparlisib	2	Unknown Status	1
DB05916	CT-011	2	Completed	1
DB14776	Camrelizumab	2	Not Yet Recruiting	1
DB14776	Camrelizumab	2	Unknown Status	1
DB00958	Carboplatin	2	Completed	2
DB14917	Ceralasertib	2	Unknown Status	1
DB05239	Cobimetinib	2	Completed	2
DB05239	Cobimetinib	2	Suspended	1
DB05239	Cobimetinib	2	Terminated	1
DB00531	Cyclophosphamide	2	Completed	1
DB08912	Dabrafenib	2	Completed	1
DB08912	Dabrafenib	2	Recruiting	1
DB08912	Dabrafenib	2	Terminated	1
DB00851	Dacarbazine	2	Completed	3
DB00851	Dacarbazine	2	Unknown Status	1
DB17157	Darleukin	2	Completed	1
DB12908	Denenicokin	2	Terminated	1
DB00004	Denileukin diftitox	2	Completed	1
DB01248	Docetaxel	2	Completed	1
DB11714	Durvalumab	2	Unknown Status	1
DB05494	Elacytarabine	2	Completed	2
DB11718	Encorafenib	2	Active Not Recruiting	1
DB11718	Encorafenib	2	Not Yet Recruiting	1
DB11718	Encorafenib	2	Recruiting	1
DB01073	Fludarabine	2	Completed	1
DB04106	Fotemustine	2	Completed	1
DB17296	Gebasaxturev	2	Completed	1
DB14865	Human interleukin-2	2	Completed	1
DB00724	Imiquimod	2	Completed	1
DB05258	Interferon alfa	2	Completed	1
DB00105	Interferon alfa-2b	2	Active Not Recruiting	1
DB00105	Interferon alfa-2b	2	Withdrawn	1
DB15131	Interferon alfa-2c	2	Withdrawn	1
DB06186	Ipilimumab	2	Completed	5
DB06186	Ipilimumab	2	Recruiting	1
DB06186	Ipilimumab	2	Terminated	1
DB01259	Lapatinib	2	Terminated	1
DB00227	Lovastatin	2	Withdrawn	1
DB17378	MVR-T3011	2	Suspended	1
DB09035	Nivolumab	2	Completed	2
DB09035	Nivolumab	2	Recruiting	1
DB01229	Paclitaxel	2	Completed	2
DB01229	Paclitaxel	2	Not Yet Recruiting	1
DB00022	Peginterferon alfa-2b	2	Active Not Recruiting	1
DB09037	Pembrolizumab	2	Active Not Recruiting	2
DB09037	Pembrolizumab	2	Completed	1
DB09037	Pembrolizumab	2	Not Yet Recruiting	1
DB09037	Pembrolizumab	2	Recruiting	2
DB12978	Pexidartinib	2	Completed	1
DB14765	Rivoceranib	2	Unknown Status	1
DB06176	Romidepsin	2	Terminated	1
DB18439	SCIB1	2	Recruiting	1
DB00020	Sargramostim	2	Completed	1
DB09153	Sodium chloride	2	Recruiting	1
DB00398	Sorafenib	2	Completed	2
DB15283	Tebentafusp	2	Terminated	1
DB00853	Temozolomide	2	Active Not Recruiting	1
DB00853	Temozolomide	2	Completed	2
DB00853	Temozolomide	2	Recruiting	1
DB00853	Temozolomide	2	Terminated	1
DB00853	Temozolomide	2	Unknown Status	1
DB04900	Thymalfasin	2	Completed	1
DB16341	Tilsotolimod	2	Recruiting	1
DB14922	Tislelizumab	2	Terminated	1
DB15043	Toripalimab	2	Recruiting	1
DB08911	Trametinib	2	Completed	1
DB08911	Trametinib	2	Recruiting	1
DB08911	Trametinib	2	Terminated	1
DB11771	Tremelimumab	2	Completed	1
DB08881	Vemurafenib	2	Completed	6
DB08881	Vemurafenib	2	Terminated	3
DB18871	Vobramitamab duocarmazine	2	Active Not Recruiting	1
DB05258	Interferon alfa	2 / 3	Completed	1
DB00034	Interferon alfa-2a	2 / 3	Completed	1
DB00008	Peginterferon alfa-2a	2 / 3	Completed	1
DB05239	Cobimetinib	3	Completed	1
DB08912	Dabrafenib	3	Completed	1
DB00851	Dacarbazine	3	Completed	3
DB17157	Darleukin	3	Recruiting	1
DB04106	Fotemustine	3	Completed	1
DB00105	Interferon alfa-2b	3	Completed	1
DB09078	Lenvatinib	3	Active Not Recruiting	2
DB17330	Onamelatucel-L	3	Unknown Status	2
DB16269	Onfekafusp alfa	3	Recruiting	1
DB01229	Paclitaxel	3	Completed	1
DB09037	Pembrolizumab	3	Active Not Recruiting	2
DB08911	Trametinib	3	Completed	1
DB08881	Vemurafenib	3	Completed	3
DB06400	Vitespen	3	Completed	1
DB16604	Fibrin	4	Completed	1
DB09222	Fibrinogen human	4	Completed	1
DB11571	Human thrombin	4	Completed	1
DB06186	Ipilimumab	4	Active Not Recruiting	1
DB08881	Vemurafenib	4	Completed	1